Supplemental material, sj-docx-1-msj-10.1177_13524585231189677 for Enhancing diversity of clinical trial populations in multiple sclerosis by Ruth Ann Marrie, Jeremy Chataway, Barbara E Bierer, Marcia Finlayson, Elena H Martinez-Lapiscina, Jennifer Panagoulias, Maria Pia Sormani, Mitzi Joi Williams and Lilyana Amezcua in Multiple Sclerosis Journal</p
Supplemental material, sj-docx-1-msj-10.1177_13524585231225711 for Real-world data on siponimod-rela...
Supplemental material, sj-docx-1-msj-10.1177_13524585231199031 for Association of MRI leptomeningeal...
Supplemental material, sj-docx-2-msj-10.1177_13524585231225711 for Real-world data on siponimod-rela...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189678 for Enhancing involvement of people w...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189678 for Enhancing involvement of people w...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189671 for Improving the efficiency of clini...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189671 for Improving the efficiency of clini...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatm...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189670 for Participant diversity in clinical...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatm...
Supplemental material, sj-docx-1-msj-10.1177_13524585221125382 for Recurrent disability progression ...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189674 for Intermediate outcomes for clinica...
Supplemental material, sj-docx-1-msj-10.1177_13524585221122210 for Leptomeningeal enhancement under ...
Supplemental material, sj-docx-1-msj-10.1177_13524585231199084 for Vaccination frequency in people n...
Supplemental material, MSJ803769_supplementary_material for Inclusion criteria used in trials of peo...
Supplemental material, sj-docx-1-msj-10.1177_13524585231225711 for Real-world data on siponimod-rela...
Supplemental material, sj-docx-1-msj-10.1177_13524585231199031 for Association of MRI leptomeningeal...
Supplemental material, sj-docx-2-msj-10.1177_13524585231225711 for Real-world data on siponimod-rela...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189678 for Enhancing involvement of people w...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189678 for Enhancing involvement of people w...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189671 for Improving the efficiency of clini...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189671 for Improving the efficiency of clini...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatm...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189670 for Participant diversity in clinical...
Supplemental material, sj-docx-2-msj-10.1177_13524585231189673 for Assessing heterogeneity of treatm...
Supplemental material, sj-docx-1-msj-10.1177_13524585221125382 for Recurrent disability progression ...
Supplemental material, sj-docx-1-msj-10.1177_13524585231189674 for Intermediate outcomes for clinica...
Supplemental material, sj-docx-1-msj-10.1177_13524585221122210 for Leptomeningeal enhancement under ...
Supplemental material, sj-docx-1-msj-10.1177_13524585231199084 for Vaccination frequency in people n...
Supplemental material, MSJ803769_supplementary_material for Inclusion criteria used in trials of peo...
Supplemental material, sj-docx-1-msj-10.1177_13524585231225711 for Real-world data on siponimod-rela...
Supplemental material, sj-docx-1-msj-10.1177_13524585231199031 for Association of MRI leptomeningeal...
Supplemental material, sj-docx-2-msj-10.1177_13524585231225711 for Real-world data on siponimod-rela...